...
首页> 外文期刊>Contemporary clinical trials >Remission from chronic opioid use Studying environmental and socioeconomic factors on recovery (RECOVER): Study design and participant characteristics
【24h】

Remission from chronic opioid use Studying environmental and socioeconomic factors on recovery (RECOVER): Study design and participant characteristics

机译:慢性阿片类药物的缓解使用研究环境和社会经济因素恢复(恢复):研究设计和参与者特征

获取原文
获取原文并翻译 | 示例
           

摘要

Few opioid use disorder (OUD) treatment studies measure meaningful life changes during long-term recovery, focusing instead on retention and abstinence. Here, we report on the design and participant characteristics of the RECOVER study, a study exploring life changes in persons with OUD for up to 24 months following participation in a Phase III trial evaluating buprenorphine extended-release monthly injection for subcutaneous use (known as RBP-6000 during development). This multisite, observational, cohort study tracks clinical, environmental, and socio-economic changes using self-administered assessments, urine drug screens (UDS), and public databases. Outcomes include demographics (e.g., patient characteristics, employment history, criminal history), lifetime and recent OUD drug use and treatment, and current health and resource use. Demographic and psychosocial characteristics are compared to a national, population-based study. RECOVER participants (N = 533) tend to be single, white, males aged 26 years or older. Mean age at first opioid use was 21.7 years; lifetime substance-related overdose was 24.2%. At first assessment, 334 (62.7%) participants reported past 7-day and 296 (55.5%) reported past 28-day opioid abstinence. Five hundred UDS were collected at the first assessment; buprenorphine (90.6%), marijuana (45.2%), and opiates (34.4%) were most commonly identified. Two hundred forty-nine (47.2%) participants reported full- or part-time employment. Participants were like a national sample with differences found for age, race/ethnicity, employment, education, and health-related quality of life. We hope that further research using this approach can provide data supporting the patient-centered development of OUD treatments and be adopted by substance use disorder studies to incorporate recovery-related, life-activity outcomes.
机译:少数阿片类药物使用障碍(Oud)治疗研究在长期恢复期间测量有意义的生活变化,重点关注保留和禁欲。在这里,我们报告了恢复研究的设计和参与者特征,一项研究探讨了在参与III期试验期间的牛伦尿嘧啶延长月注射液中的牛仔症延长月注于皮下使用后24个月的人员(称为RBP) -6000在开发期间)。这种多路径,观察,队列研究轨道使用自我管理的评估,尿药物屏幕和公共数据库来追踪临床,环境和社会经济变化。结果包括人口统计学(例如,患者特征,就业历史,犯罪史),终身和最近的牛药使用和治疗,以及当前的健康和资源使用。将人口和心理社会特征与全国人口的研究进行比较。恢复参与者(n = 533)往往是单身,白色,26岁或以上的男性。第一次阿片类药物使用的平均年龄是21.7岁;寿命与物质相关的过量为24.2%。在第一次评估中,334名(62.7%)参与者报告过7天和296名(55.5%)报告过28天的阿片类药物禁欲。在第一次评估中收集五百个UDS; Buprenorphine(90.6%),大麻(45.2%)和阿片类药物(34.4%)最常确定。二百四十九(47.2%)参与者报告了全部或兼职工作。参与者就像一个国家样本,差异为年龄,种族/种族,就业,教育和与健康有关的生活质量。我们希望使用这种方法的进一步研究可以提供支持患者居住的oud治疗发展的数据,并通过物质使用障碍研究采用,以纳入恢复相关的生命活动结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号